Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you take lisinopril for blood pressure and are considering Mounjaro for weight management, the key question is whether the combination is safe for you specifically — and that is always a clinical decision. Lisinopril and Mounjaro are not contraindicated together, but there are real interactions worth understanding before you start. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber must assess your full medical picture, including any existing medications, before it can be prescribed. What follows is a factual guide to the points that matter most.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Lisinopril works by blocking the enzyme that tightens blood vessels, keeping blood pressure lower. Mounjaro (tirzepatide) doesn't target blood pressure directly, but in clinical trials (including SURMOUNT-1, published in the New England Journal of Medicine) participants lost substantial body weight, and weight loss consistently brings blood pressure down on its own. When you combine an ACE inhibitor that is already doing its job with a medicine that independently lowers blood pressure through weight reduction, the result can sometimes be blood pressure that drops further than either drug would produce alone.
That isn't automatically a problem — for many people with hypertension and obesity, it is precisely the goal. But it can become one if blood pressure falls too low too quickly, particularly in the early weeks of Mounjaro treatment when weight is starting to shift. Symptoms of low blood pressure include dizziness when you stand, lightheadedness, or feeling faint. If those appear, contact your GP or prescriber promptly rather than waiting for your next routine review.
This is a question our prescribers hear most weeks from people already on antihypertensives: the answer is not to avoid Mounjaro, but to make sure whoever manages your blood pressure knows the full picture before and during treatment.
ACE inhibitors, including lisinopril, depend on adequate kidney perfusion to work safely. They are well-tolerated in most people, but they are known to be sensitive to changes in fluid balance. NHS guidance on tirzepatide lists nausea, vomiting and diarrhoea among the most common side effects, particularly in the first weeks of treatment or after a dose increase. If those side effects are significant and you are not drinking enough to compensate, dehydration can follow. Dehydration reduces blood flow to the kidneys, and when the kidneys are already under the influence of an ACE inhibitor, that reduction can push kidney function outside its normal range, a state sometimes called acute kidney injury.
In practice, most people on Mounjaro manage their gastrointestinal side effects without any kidney problem at all. The risk is not a reason to rule out the combination; it is a reason to stay well-hydrated, to tell your prescriber if vomiting or diarrhoea is severe, and to know the warning signs: reduced urination, swelling, or unusual fatigue alongside the gastrointestinal symptoms. Electrolyte levels (particularly potassium, which lisinopril can raise slightly) may also be worth monitoring, depending on your baseline blood tests. Your prescriber and GP can advise on that.
Here is a point that catches people off-guard. Mounjaro is not a short-term fix; for most people it is a longer-term medicine. As weight falls over months, blood pressure tends to fall with it. For some people, that means the dose of lisinopril they needed at the start of treatment is higher than they need a year in. Continuing the same antihypertensive dose when blood pressure has already come down through weight loss can lead to it sitting lower than is ideal.
This is not a complication unique to Mounjaro, it applies to any effective weight-loss treatment. But it does mean that regular blood pressure monitoring matters, and that whoever prescribes your lisinopril should know you are on tirzepatide. If you are looking at the broader picture of how tirzepatide works as a treatment, the cardiovascular data are worth reading alongside the weight-loss results. You may also find our overview of Mounjaro useful for understanding the licensed schedule and what to expect at each stage.
For context on what private Mounjaro treatment involves financially, our Mounjaro cost page sets out what is included in a single transparent price. Some people also find it helpful to read about Mounjaro and ramipril, since ramipril is another ACE inhibitor and the clinical principles overlap closely with lisinopril.
The practical steps are straightforward. Tell your prescriber (at consultation stage) that you take lisinopril, what dose you are on, and whether your blood pressure is currently well-controlled. That context shapes how your case is reviewed. Inform your GP at the same time so they can flag any concerns from their side and plan monitoring if needed. Our clinical team assesses exactly these co-medications as part of every consultation; it is not information you need to volunteer nervously, it is information we ask for. If you are also managing a related condition, our page on Mounjaro and erectile dysfunction covers another area where blood pressure medicines and Mounjaro can intersect.
For information on retinal changes in people with diabetes starting Mounjaro, Mounjaro and retinopathy addresses that separately, relevant if you also have type 2 diabetes alongside hypertension. The MHRA's Yellow Card service is also there to report any unexpected side effects once you are on treatment. If you are ready to discuss your own circumstances with a GPhC-registered prescriber, the right next step is to speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.